ATE512985T1 - Diagnostische und therapeutische anwendungen von löslichem lhcgr-protein - Google Patents

Diagnostische und therapeutische anwendungen von löslichem lhcgr-protein

Info

Publication number
ATE512985T1
ATE512985T1 AT05734038T AT05734038T ATE512985T1 AT E512985 T1 ATE512985 T1 AT E512985T1 AT 05734038 T AT05734038 T AT 05734038T AT 05734038 T AT05734038 T AT 05734038T AT E512985 T1 ATE512985 T1 AT E512985T1
Authority
AT
Austria
Prior art keywords
lhcgr
protein
soluble
diagnostic
therapeutic uses
Prior art date
Application number
AT05734038T
Other languages
English (en)
Inventor
Subhasis Banerjee
Original Assignee
Subhasis Banerjee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Subhasis Banerjee filed Critical Subhasis Banerjee
Application granted granted Critical
Publication of ATE512985T1 publication Critical patent/ATE512985T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT05734038T 2004-04-15 2005-04-15 Diagnostische und therapeutische anwendungen von löslichem lhcgr-protein ATE512985T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0408449.7A GB0408449D0 (en) 2004-04-15 2004-04-15 Diagnostic and therapeutic applications of soluble lhcge protein
PCT/GB2005/001473 WO2005100397A1 (en) 2004-04-15 2005-04-15 Diagnostic and therapeutic applications of soluble lhcgr protein

Publications (1)

Publication Number Publication Date
ATE512985T1 true ATE512985T1 (de) 2011-07-15

Family

ID=32320901

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05734038T ATE512985T1 (de) 2004-04-15 2005-04-15 Diagnostische und therapeutische anwendungen von löslichem lhcgr-protein

Country Status (7)

Country Link
US (1) US7892753B1 (de)
EP (1) EP1751189B1 (de)
AT (1) ATE512985T1 (de)
AU (1) AU2005233362A1 (de)
CA (1) CA2563578A1 (de)
GB (1) GB0408449D0 (de)
WO (1) WO2005100397A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1966612B1 (de) * 2005-12-29 2010-03-24 Humanitas Mirasole S.p.A. Diagnostischer test für entzündliche endothelfehlfunktionen bei schwangerschaften
CN101529248A (zh) * 2006-09-14 2009-09-09 佐拉生物科学有限公司 作为用于早期预测自身免疫和1型糖尿病风险之工具的生物流体代谢物谱分析
WO2016010786A1 (en) * 2014-07-15 2016-01-21 Zietchick Research Institute, Llc Method for preventing or treating ocular disorders
EP3273994B1 (de) 2015-03-27 2021-12-01 University of Southern California Car-t-zelltherapie gegen lhr zur behandlung von soliden tumoren
WO2016162037A1 (en) * 2015-04-08 2016-10-13 Rigshospitalet Copenhagen Universtiy Hospital Lhcgr for use in diagnosing and monitoring of andrological diseases
CA2987992A1 (en) 2015-06-04 2016-12-08 University Of Southern California Lym-1 and lym-2 targeted car cell immunotherapy
JP2020501512A (ja) * 2016-09-23 2020-01-23 ユニバーシティ オブ サザン カリフォルニア キメラ抗原受容体およびその組成物ならびにそれらの使用の方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
DE69131393T2 (de) 1990-09-10 1999-11-04 Takeda Chemical Industries Ltd Menschlicher Rezeptor für luteinisierendes Hormon und Choriongonadotropin
JP2001519650A (ja) 1996-04-15 2001-10-23 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ 可溶性７回貫膜ドメインｇタンパク質共役受容体、組成物及び方法
EP1022027A1 (de) 1999-01-22 2000-07-26 Applied Research Systems ARS Holding N.V. Antagonisten von Tumornecrosefaktor und ihre Verwendungen gegen Endometriose
WO2002061087A2 (en) * 2000-12-19 2002-08-08 Lifespan Biosciences, Inc. Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides

Also Published As

Publication number Publication date
CA2563578A1 (en) 2005-10-27
WO2005100397A1 (en) 2005-10-27
US7892753B1 (en) 2011-02-22
AU2005233362A1 (en) 2005-10-27
EP1751189A1 (de) 2007-02-14
GB0408449D0 (en) 2004-05-19
EP1751189B1 (de) 2011-06-15

Similar Documents

Publication Publication Date Title
ATE512985T1 (de) Diagnostische und therapeutische anwendungen von löslichem lhcgr-protein
DE60220719D1 (de) Antikörper gegen das muc18-antigen
ATE389404T1 (de) Kappa-opioid-rezeptor-liganden
BRPI0408247A (pt) usos de antagonistas e agonistas de il-23 e reagentes relacionados
EA200600055A1 (ru) Агонисты рецептора меланокортина 4 (мк4 ) и их применение
ATE394121T1 (de) Verwendung von antikörpern gegen das muc18- antigen
DE60143798D1 (de) Immunspezifisch bindende antikörper gegen blys
WO2004058171A3 (en) Antibodies against gpr64 and uses thereof
BR0116379A (pt) Antagonistas de receptor y5 de neuropeptìdeo y de uréia de heteroarila
PA8564001A1 (es) Aza-arilpiperazinas
ATE486890T1 (de) Ephb-rezeptorbindende peptide
HUP0301877A2 (hu) Aromatáz inhibitorok és monoklonális anti-HER2 ellenanyagok mint tumorellenes szerek
WO2008137838A3 (en) Interferon alpha-induced pharmacodynamic markers
ZA200606834B (en) 1-Aminocyclohexane derivatives for the treatment of agitation and other behavioral disorders, especially those associated with Alzheimer's disease
ATE484505T1 (de) 5-sulfanylmethylä1,2,4ütriazolä1,5-aüpyrimidin- - olderivate als cxcr2-antagonisten
UY27003A1 (es) Productos radiofarmacéuticos para el diagnóstico de la enfermedad de alzheimer
AU2003255820A8 (en) Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
DE60141297D1 (de) Gegen das menschliche bst2 antigen gerichteter monoklonaler antikörper
BRPI0407031A (pt) Composições e métodos para tratamento de câncer empregando igsf9 e liv-1
WO2006029838A3 (en) Secreted polypeptide species involved in alzheimer’s disease
DE60036469D1 (de) 17867, eine menschliche aminopeptidase
TNSN04101A1 (fr) ASSOCIATIONS PHARMACEUTIQUES D'UN AGONISTE DE RECEPTEUR D'ADENOSINE A2a ET D'UN AGONISTE DE RECEPTEUR ADRENERGIQUE B2
Liew et al. The role of aldosterone receptor blockade in the management of cardiovascular disease
Akın Takmaz et al. Ketamine combined with morphine for the management of cancer pain in a patient with meperidine tolerance and addiction
Hars et al. An epidemic of west nile fever in the south of France: Results of an epidemiologic survey on wild birds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties